Foot loading with an ankle-foot orthosis: the accuracy of an integrated physical strain trainer

1 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, April 24, 2013

2 Deep wound cultures and bone biopsy in diabetic foot osteomyelitis Diabetes/Metabolism Research and Reviews, May 8, 2013    Review Article

3 Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab Clinical Cancer Research, May 8, 2013

4 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, May 3, 2013

5 Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy Mycoses, April 26, 2013

6 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, May 3, 2013

7 Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus Acta Diabetologia, May 2, 2013    Review Article

8 Role of Reflexology and Antiepileptic Drugs in Managing Intractable Epilepsy - a Randomized Controlled Trial Research in Complementary Medicine, May 6, 2013

9 Heart failure in hospitalized patients with diabetic foot ulcers: clinical characteristics and its relationship to prognosis Journal of Diabetes, May 9, 2013    Review Article

10 The effectiveness of footwear as an intervention to prevent or to reduce biomechanical risk factors associated with diabetic foot ulceration: A systematic review Journal of Diabetes and its Complications, May 6, 2013    Evidence Based Medicine    Review Article